NanoViricides Inc (NNVC)

[BonelessCat]

Oh, you want recent work after 2005? Here are only a few of dozens of papers in oncology research with Menon's name. Note the names in the second paper published in 2009 include co-authors from his Pfizer days. I can't help but notice Shih isn't in any of the lists of authors from Pfizer generated publications or any co-authors from the award winning Pfizer team after 2002, while Menon's name appears repeatedly with those same members of that team right up to 2009. Don't you think that suggests something about Shih rather than Menon?

Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
Gilmore JL, Gonterman RM, Menon K, Lorch G, Riese DJ 2nd, Robling A, Foley J.

Mol Cancer Res. 2009 Oct;7(10):1714-28. Epub 2009 Oct 13.


Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.

Mitsiades CS, Rouleau C, Echart C, Menon K, Teicher B, Distaso M, Palumbo A, Boccadoro M, Anderson KC, Iacobelli M, Richardson PG.

Clin Cancer Res. 2009 Feb 15;15(4):1210-21.


The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
Rouleau C, Menon K, Boutin P, Guyre C, Yoshida H, Kataoka S, Perricone M, Shankara S, Frankel AE, Duesbery NS, Vande Woude G, Biemann HP, Teicher BA.
Source: Int J Oncol. 2008 Apr;32(4):739-48.

Genzyme Corporation, Framingham, MA 01701, USA. [e-mail]